Electrophoresis-Based Approach for Characterizing Dendrimer-Protein Interactions: A Proof-of-Concept Study.

ACS Biomater Sci Eng

Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts 02139, United States.

Published: June 2024

Improving the clinical translation of nanomedicine requires better knowledge about how nanoparticles interact with biological environments. As researchers are recognizing the importance of understanding the protein corona and characterizing how nanocarriers respond in biological systems, new tools and techniques are needed to analyze nanocarrier-protein interactions, especially for smaller size (<10 nm) nanoparticles like polyamidoamine (PAMAM) dendrimers. Here, we developed a streamlined, semiquantitative approach to assess dendrimer-protein interactions using a nondenaturing electrophoresis technique combined with mass spectrometry. With this protocol, we detect fluorescently tagged dendrimers and proteins simultaneously, enabling us to analyze when dendrimers migrate with proteins. We found that PAMAM dendrimers mostly interact with complement proteins, particularly C3 and C4a, which aligns with previously published data, verifying that our approach can be used to isolate and identify dendrimer-protein interactions.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsbiomaterials.3c01579DOI Listing

Publication Analysis

Top Keywords

electrophoresis-based approach
4
approach characterizing
4
characterizing dendrimer-protein
4
dendrimer-protein interactions
4
interactions proof-of-concept
4
proof-of-concept study
4
study improving
4
improving clinical
4
clinical translation
4
translation nanomedicine
4

Similar Publications

Cell-free DNA (cfDNA) is present in healthy individuals but is elevated in those undergoing physical exertion, trauma, sepsis, and certain cancers. Maintaining cfDNA concentrations is vital for immune homeostasis and preventing inflammatory responses. Understanding cfDNA release and clearance is essential for using cfDNA as a biomarker in clinical diagnostics.

View Article and Find Full Text PDF

Early-stage Alzheimer's disease profiling in blood achieved by multiplexing aptamer-SERS biosensors.

Biosens Bioelectron

January 2025

CAS Key Laboratory of Ion-beam Bioengineering, Institute of Intelligent Machines, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; Science Island Branch of Graduate School, University of Science and Technology of China, Hefei, 230026, China. Electronic address:

Neurological disorders are the second leading cause of death globally, with Alzheimer's disease (AD) emerging as a significant contributor, responsible for 276 million cases in disability-adjusted life years. Conventional diagnostic methods are often invasive, costly, and place a considerable strain on global healthcare systems. In this study, we presented an innovative and efficient strategy for AD assessment through blood profiling using a multiwell glass chip integrated with aptamer-based surface-enhanced Raman scattering (SERS) biosensors.

View Article and Find Full Text PDF

A capillary electrophoresis-based assay for carrier screening of the hotspot mutations in the gene.

Heliyon

October 2024

Department of Prenatal Diagnosis, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu, 210004, People's Republic of China.

Molecular genetic analysis of the cytochrome P450 family 21 subfamily A member 2 () gene is challenging owing to the highly homologous with its pseudogene. A reliable approach for the large-scale population screening of is required. This study aimed to establish and evaluate a capillary electrophoresis-based assay for hotspot mutation carrier screening of the gene.

View Article and Find Full Text PDF

Assessment of adeno-associated virus purity by capillary electrophoresis-based western.

Mol Ther Methods Clin Dev

September 2024

Analytical Development, Sangamo Therapeutics, 501 Canal Blvd, Richmond, CA 94804, USA.

A rigorous analytical assessment of recombinant adeno-associated virus (rAAV)-based drug products is critical for their successful development as clinical candidates. It is especially important to ascertain high purity while simultaneously ensuring low levels of impurities in the final drug product. One approach to evaluate the purity of rAAV drug products is to determine the relative stoichiometry of the three viral proteins (VPs) that comprise an rAAV capsid, and the levels of impurities in the final drug product.

View Article and Find Full Text PDF

Introduction: Yangxinshi tablet (YXST) is a effective traditional Chinese medicine in treating cardiovascular diseases such as heart failure and myocardial infarction.

Objectives: This study aims to develop a method for screening thrombin inhibitors from YXST using an online immobilized enzyme microreactor (IMER) based on capillary electrophoresis (CE).

Materials And Methods: Thrombin (THR) was immobilized on the capillary's inner wall using polydopamine (PDA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!